pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
spevatamig
Adenocarcinoma Of The Gastroesophageal Junction
Phanes Therapeutics Inc
0 catalysts
Phase 2
sugemalimab
Cejemly (sugemalimab [INN])
Natural Killer Cell Lymphomas
CStone Pharmaceuticals Co Ltd
0 catalysts
Marketed
sunitinib malate
Sunitinib Malate (sunitinib malate)
Gastrointestinal Stromal Tumor (GIST)
Wanbang Biopharmaceuticals Co Ltd
0 catalysts
Marketed
← prev
page 58 of 62
next →
131
Pain89
Neurology1
sunvozertinib
Zegfrovy (sunvozertinib)
Non-Small Cell Lung Cancer
Dizal Pharmaceutical Co Ltd
0 catalysts
Phase 2
suratadenoturev
Telomelysin (suratadenoturev)
Adenocarcinoma Of The Gastroesophageal Junction
Oncolys BioPharma Inc
0 catalysts
Phase 2
surovatamig
surovatamig [INN]
B-Cell Non-Hodgkin Lymphoma
$AZNASTRAZENECA PLC
0 catalysts
Phase 2
surufatinib
Solid Tumor
Fibroblast growth factor receptor 1Vascular endothelial growth factor receptor
$HCMHUTCHMED (China) Ltd
0 catalysts
Phase 2
surzebiclimab
Recurrent Head And Neck Squamous Cell Carcinoma
$ONCBeOne Medicines Ltd.
0 catalysts
Phase 3
tafasitamab
Monjuvi (tafasitamab)
Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associated Lymphoid Tissue o…
B-lymphocyte antigen CD19
$INCYINCYTE CORP
0 catalysts
Phase 2
tagitanlimab
tagitanlimab [INN]
Nasopharyngeal Cancer
Hbm Holdings Ltd
0 catalysts
Phase 2
tagmokitug
Adenocarcinoma Of The Gastroesophageal Junction
$CHRSCoherus Oncology, Inc.
0 catalysts
Phase 2
tagraxofusp
Elzonris (tagraxofusp-erzs)
Refractory Acute Myeloid Leukemia
Elongation factor 2Interleukin-3 receptor subunit alpha
Stemline Therapeutics Inc
0 catalysts
Marketed
talazoparib tosylate
Talzenna (talazoparib tosylate)
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Poly [ADP-ribose] polymerase 1Poly [ADP-ribose] polymerase 2
$PFEPFIZER INC
0 catalysts
Marketed
taletrectinib adipate
Ibtrozi (taletrectinib adipate)
Solid Tumor
$NUVBNuvation Bio Inc.
0 catalysts
Marketed
talimogene laherparepvec
Imlygic (talimogene laherparepvec)
Metastatic Melanoma
$AMGNAMGEN INC
0 catalysts
Phase 2
tambiciclib
Diffuse Large B-Cell Lymphoma
$SLSSELLAS Life Sciences Group, Inc.
0 catalysts
Phase 2
tambotatug pelitecan
Nasopharyngeal Cancer
F. Hoffmann-La Roche Ltd
0 catalysts
Marketed
tamoxifen citrate
Soltamox (tamoxifen citrate)
Breast Cancer
Mayne Pharma USA Inc
0 catalysts
Phase 2
tasquinimod
tasquinimod [INN]
Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)
Active Biotech AB
0 catalysts
Preclinical
taurolidine
taurolidine [INN]
Neuroblastoma
$CRMDCorMedix Inc.
0 catalysts
Phase 2
tebapivat
Sickle Cell Disease
$AGIOAGIOS PHARMACEUTICALS, INC.
0 catalysts
Marketed
tebentafusp
Kimmtrak (tebentafusp)
Metastatic Uveal Melanoma
$IMCRImmunocore Holdings plc
0 catalysts
Phase 2
tegavivint
tegavivint [INN]
Hepatocellular Carcinoma
Iterion Therapeutics Inc
0 catalysts
Phase 2
telisotuzumab adizutecan
telisotuzumab adizutecan [INN]
Gastric Cancer
$ABBVAbbVie Inc.
0 catalysts
Marketed
telisotuzumab vedotin
Emrelis (telisotuzumab vedotin-tllv)
Non-Small Cell Lung Cancer
$ABBVAbbVie Inc.
0 catalysts
Marketed
telotristat ethyl
Xermelo (telotristat ethyl)
Carcinoid Syndrome (Malignant Carcinoid Syndrome)
TerSera Therapeutics LLC
0 catalysts
Marketed
temozolomide
Temozolomide (temozolomide)
Anaplastic Astrocytoma
Areva Pharmaceuticals Inc
0 catalysts
Marketed
temsirolimus
Temsirolimus (temsirolimus)
Metastatic Renal Cell Carcinoma
Accord Healthcare Inc
0 catalysts
Marketed
tepotinib hydrochloride
Tepmetko (tepotinib hydrochloride)
Non-Small Cell Lung Cancer
EMD Serono Inc
0 catalysts
Phase 2
testosterone
Testagen TDS (testosterone [INN])
Male Hypogonadism
Transdermal Delivery Solutions Corp
0 catalysts